National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report https://bit.ly/3xouJxV April 30, 2022 at 03:59AM NDTV News - Topstories from NDTV News - Topstories https://bit.ly/3s0IsYr
via IFTTT
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report https://bit.ly/3xouJxV April 30, 2022 at 03:59AM NDTV News - Topstories from NDTV News - Topstories https://bit.ly/3s0IsYr
via IFTTT
Comments
Post a Comment